Provided by Tiger Trade Technology Pte. Ltd.

Precision Biosciences Inc

3.96
-0.1100-2.70%
Post-market: 3.960.00000.00%16:10 EST
Volume:223.67K
Turnover:883.75K
Market Cap:95.32M
PE:-0.48
High:4.09
Open:4.06
Low:3.75
Close:4.07
52wk High:8.82
52wk Low:3.53
Shares:24.07M
Float Shares:22.82M
Volume Ratio:0.70
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3225
EPS(LYR):1.04
ROE:-205.16%
ROA:-45.34%
PB:5.73
PE(LYR):3.81

Loading ...

Feb 11, 2026

Major Issues Report

Form 8-K - Current report
Jan 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Dec 30, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities